SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL IN THE PRIMARY-TREATMENT OF METASTATIC COLORECTAL-CARCINOMA

被引：15

作者：

AJANI, JA

KANOJIA, MD

BEDIKIAN, AY

KORINEK, JK

STEIN, SH

ESPINOZA, EG

BODEY, GP

机构：

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1985年 / 8卷 / 01期

关键词：

D O I：

10.1097/00000421-198502000-00050

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：69 / 71

页数：3

共 10 条

[1]

BENZ C, 1981, CANCER RES, V41, P994

[2]

CANTRELL JE, 1982, CANCER TREAT REP, V66, P1563

[3]

FERNANDES DJ, 1981, CANCER TREAT REP, V65, P29

[4]

KEMENY N, 1982, P ASCO, V1, P95

[5] 5-FLUOROURACIL AND METHOTREXATE COMBINATION CHEMOTHERAPY - THE EFFECT OF DRUG SCHEDULING [J].

MULDER, JH ;

SMINK, T ;

VANPUTTEN, M .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (07) :831-837

[6]

PANASCI L, 1982, P AN M AM SOC CLIN, V1, P101

[7]

PLOTKIN D, 1980, P ASCO, V1, P80

[8] IMPROVING THE ANTI-TUMOR ACTIVITY OF 5-FLUOROURACIL BY INCREASING ITS INCORPORATION INTO RNA VIA METABOLIC MODULATION [J].

SPIEGELMAN, S ;

SAWYER, R ;

NAYAK, R ;

RITZI, E ;

STOLFI, R ;

MARTIN, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (08) :4966-4970

[9]

TISMAN G, 1980, CANCER TREAT REP, V64, P829

[10]

WEINERMAN B, 1982, CANCER TREAT REP, V66, P1553

← 1 →